Bioserenity raised €24M in a funding round in Nov 2023. The company is based in Paris, France. Investors in the round: Jolt Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €24M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
